154 related articles for article (PubMed ID: 1713051)
1. The effect of a somatostatin analogue on the release of hormones from human midgut carcinoid tumour cells.
Wängberg B; Nilsson O; Theodorsson E; Dahlström A; Ahlman H
Br J Cancer; 1991 Jul; 64(1):23-8. PubMed ID: 1713051
[TBL] [Abstract][Full Text] [Related]
2. Adrenergic control of serotonin release from a midgut carcinoid tumour.
Nilsson O; Grönstad KO; Goldstein M; Skolnik G; Dahlström A; Ahlman H
Int J Cancer; 1985 Sep; 36(3):307-12. PubMed ID: 2411674
[TBL] [Abstract][Full Text] [Related]
3. Serotonin-producing carcinoid tumour cells in long-term culture. Studies on serotonin release and morphological features.
Ahlund L; Nilsson O; Kling-Petersen T; Wigander A; Theodorsson E; Dahlström A; Ahlman H
Acta Oncol; 1989; 28(3):341-6. PubMed ID: 2663047
[TBL] [Abstract][Full Text] [Related]
4. The effect of somatostatin on 5-hydroxytryptamine release from a carcinoid tumor.
Lawrence JP; Ishizuka J; Haber B; Townsend CM; Thompson JC
Surgery; 1990 Dec; 108(6):1131-4; discussion 1134-5. PubMed ID: 1978946
[TBL] [Abstract][Full Text] [Related]
5. Carcinoid tumour cells in long-term culture: release of serotonin but not of tachykinins on stimulation with adrenoceptor agonists.
Ahlman H; Ahlund L; Nilsson O; Skolnik G; Theodorsson E; Dahlström A
Int J Cancer; 1988 Oct; 42(4):506-10. PubMed ID: 2902016
[TBL] [Abstract][Full Text] [Related]
6. The effect of somatostatin analogue SMS 201-995 on serotonin levels in the medium of primary carcinoid cell cultures.
Jacobsen MB; Hanssen LE; Bratlie J
Scand J Gastroenterol; 1992 Dec; 27(12):1077-83. PubMed ID: 1475626
[TBL] [Abstract][Full Text] [Related]
7. SMS 201-995 and provocation tests in preparation of patients with carcinoids for surgery or hepatic arterial embolization.
Ahlman H; Ahlund L; Dahlström A; Martner J; Stenqvist O; Tylén U
Anesth Analg; 1988 Dec; 67(12):1142-8. PubMed ID: 2461665
[TBL] [Abstract][Full Text] [Related]
8. Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush.
Balks HJ; Conlon JM; Creutzfeldt W; Stöckmann F
Eur J Clin Pharmacol; 1989; 36(2):133-7. PubMed ID: 2470592
[TBL] [Abstract][Full Text] [Related]
9. Secretory patterns of tryptophan metabolites in midgut carcinoid tumor cells.
Westberg G; Ahlman H; Nilsson O; Illerskog A; Wängberg B
Neurochem Res; 1997 Aug; 22(8):977-83. PubMed ID: 9239753
[TBL] [Abstract][Full Text] [Related]
10. A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake.
Kölby L; Bernhardt P; Ahlman H; Wängberg B; Johanson V; Wigander A; Forssell-Aronsson E; Karlsson S; Ahrén B; Stenman G; Nilsson O
Am J Pathol; 2001 Feb; 158(2):745-55. PubMed ID: 11159212
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of delta sleep-inducing peptide and serotonin in midgut carcinoid tumour cells in vivo and in vitro.
Ahlman H; Ahlund L; Nilsson O; Dahlström A; Bjartell A; Ekman R
Int J Cancer; 1989 Oct; 44(4):641-7. PubMed ID: 2793237
[TBL] [Abstract][Full Text] [Related]
12. On the mode of action of the pentagastrin test in the carcinoid syndrome.
Grönstad KO; Nilsson O; Hedman I; Skolnik G; Dahlström A; Ahlman H
Scand J Gastroenterol; 1985 May; 20(4):508-11. PubMed ID: 4023617
[TBL] [Abstract][Full Text] [Related]
13. Presence of IGF-I in human midgut carcinoid tumours--an autocrine regulator of carcinoid tumour growth?
Nilsson O; Wängberg B; Theodorsson E; Skottner A; Ahlman H
Int J Cancer; 1992 May; 51(2):195-203. PubMed ID: 1314781
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
Nilsson O; Kölby L; Wängberg B; Wigander A; Billig H; William-Olsson L; Fjälling M; Forssell-Aronsson E; Ahlman H
Br J Cancer; 1998 Feb; 77(4):632-7. PubMed ID: 9484822
[TBL] [Abstract][Full Text] [Related]
15. Tachykinin production by carcinoid tumours in culture.
Norheim I; Wilander E; Oberg K; Theodorsson-Norheim E; Lundqvist ML; Lindgren P; Bergh J
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):689-95. PubMed ID: 3477459
[TBL] [Abstract][Full Text] [Related]
16. Carcinoids and carcinoid syndrome.
Creutzfeldt W; Stöckmann F
Am J Med; 1987 May; 82(5B):4-16. PubMed ID: 2884878
[No Abstract] [Full Text] [Related]
17. Unexpected growth-stimulatory effect of somatostatin analogue on cultured human pancreatic carcinoid cells.
Ishizuka J; Beauchamp RD; Evers BM; Townsend CM; Thompson JC
Biochem Biophys Res Commun; 1992 Jun; 185(2):577-81. PubMed ID: 1351720
[TBL] [Abstract][Full Text] [Related]
18. Presence of nerve growth factor-like immunoreactivity in carcinoid tumour cells and induction of a neuronal phenotype in long-term culture.
Ahlman H; Wigander A; Mölne J; Nilsson O; Karlsson JE; Theodorsson E; Dahlström A
Int J Cancer; 1989 May; 43(5):949-55. PubMed ID: 2654026
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide K-(1-24)-peptide: storage and release by carcinoid tumors.
Conlon JM; Deacon CF; Grimelius L; Cedermark B; Murphy RF; Thim L; Creutzfeldt W
Peptides; 1988; 9(4):859-66. PubMed ID: 3226960
[TBL] [Abstract][Full Text] [Related]
20. Octreotide inhibition of serotonin-induced ileal chloride secretion.
Hurst RD; Ballantyne GH; Modlin IM
J Surg Res; 1995 Dec; 59(6):631-5. PubMed ID: 8538158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
